Congressional Democrats report that President Trump's pharmaceutical stock holdings grew to as much as $56.2 million, including firms benefiting from Medicare drug negotiation exemptions in Republicans' 2025 law. The White House denies conflicts of interest, saying the portfolio is independently managed.
Trump Pharma Holdings Jump to $56M After Medicare Exemption
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →